Article
The dual role of the TSC complex in cancer.
Trends in molecular medicine - 1 May 2025
Hartung Josephine, Müller Christine, Calkhoven Cornelis F
Abstract excerpt
The tuberous sclerosis complex (TSC1/TSC2/TBC1D7) primarily functions to inhibit the mechanistic target of rapamycin complex 1 (mTORC1), a crucial regulator of cell growth. Mutations in TSC1 or TSC2 cause tuberous sclerosis complex (TSC), a rare autosomal dominant genetic disorder marked by benign tumors in multiple organs that rarely progress to malignancy. Traditionally, TSC proteins are considered tumor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
